Teladoc Health, Inc. (TDOC) - 2025 Annual Report (10-K) Summary
Business Context and Reporting Period
This summary covers the Annual Report on Form 10-K for Teladoc Health, Inc. for the fiscal year ended December 31, 2025. Teladoc Health operates as the global leader in virtual care with two reportable segments: Integrated Care (B2B virtual medical services, chronic care, and mental health) and BetterHelp (direct-to-consumer virtual mental health therapy). As of December 31, 2025, the company served approximately 102 million members in the U.S. and completed 17.1 million telehealth visits globally in 2025.
Key Financial Metrics
| Metric (in millions, except per share) | 2025 | 2024 | Variance |
|---|---|---|---|
| Total Revenue | $2,530.0 | $2,569.6 | (2)% |
| Net Loss | $(200.3) | $(1,001.2) | 80% Improvement |
| Net Loss Per Share (Basic/Diluted) | $(1.14) | $(5.87) | 81% Improvement |
| Adjusted EBITDA | $281.1 | $310.7 | (10)% |
| Operating Cash Flow | $294.4 | $293.7 | 0.2% |
| Free Cash Flow | $166.9 | $169.6 | (2)% |
| Cash and Cash Equivalents | $781.1 | $1,298.3 | (40)% |
| Goodwill Impairment Charge | $71.8 | $790.0 | (91)% |
Material Changes vs. Prior Period
- Revenue Decline: Total revenue decreased 2% to $2.53 billion. This was driven by a 9% decline in BetterHelp revenue ($950.4 million) due to a 5% drop in paying users, partially offset by a 3% increase in Integrated Care revenue ($1.58 billion) aided by acquisitions (Catapult Health, Telecare, Uplift).
- Significant Loss Reduction: Net loss improved significantly from $1.0 billion in 2024 to $200.3 million in 2025. This improvement was largely due to a $718 million reduction in goodwill impairment charges (from $790 million in 2024 to $71.8 million in 2025) and lower stock-based compensation ($80.4 million vs. $146.0 million).
- Segment Performance:
- Integrated Care: Adjusted EBITDA increased 3% to $239.2 million. U.S. members grew 9% to 101.8 million, though average monthly revenue per member declined to $1.29.
- BetterHelp: Adjusted EBITDA fell 46% to $41.9 million. Paying users decreased to 0.39 million. Marketing spend decreased 7% to $518.5 million.
- Debt Repayment: The company repaid $550.6 million in convertible senior notes (Livongo Notes and 2025 Notes) upon maturity in 2025. As of year-end, $1.0 billion of 2027 Convertible Senior Notes remained outstanding.
Guidance, Outlook, and Risks
- Restructuring Outlook: Management expects to incur pre-tax restructuring costs of $15.0 million to $20.0 million in 2026 to drive efficiency, with approximately $9.0 million to $11.0 million expected in Q1 2026.
- Amortization Impact: A brand transition strategy for chronic care management will increase amortization expense by $30.7 million in 2026.
- Goodwill Risk: Following the year-end, the company's market capitalization declined below its book value. Management noted that if this decline is sustained, it could trigger further goodwill impairment testing in the next reporting period.
- Regulatory Environment: The company faces ongoing risks related to state corporate practice of medicine laws (recently strengthened in Oregon and California) and potential changes to Medicare billing rules for non-mental health telehealth services originating from a patient's home.
- Strategic Focus: Continued investment in AI and machine learning to enhance care delivery, alongside efforts to expand insurance coverage for BetterHelp services to improve user conversion and retention.
Key Facts for Investor Verification
- Profitability Path: Verify the sustainability of the loss reduction, noting it was heavily influenced by the absence of the massive $790 million goodwill impairment recorded in 2024.
- BetterHelp User Trends: Monitor the 5% decline in BetterHelp paying users and the effectiveness of the new insurance coverage rollout in reversing this trend.
- Goodwill Impairment Exposure: Assess the risk of future non-cash impairment charges given the recent decline in market capitalization below book value.
- Debt Covenants: Confirm compliance with the new Revolving Credit Facility covenants (max 3.5:1 secured net leverage ratio) as the company manages its $1.0 billion 2027 convertible notes.
- Regulatory Compliance: Track legislative developments in states like Washington, Maine, Connecticut, and North Carolina regarding corporate practice of medicine laws that could impact the company's operational model.